课题基金 / 基金详情

The role of VLA proteins and fibronectin in the activation of synovial cells from rheumatoid arthritis.

The role of VLA proteins and fibronectin in the activation of synovial cells from rheumatoid arthritis.
VLA 蛋白和纤连蛋白在类风湿性关节炎滑膜细胞激活中的作用。
批准号:
03670333
负责人:
MATSUYAMA Takami
金额:
$1.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

MATSUYAMA Takami的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Title : The role of VLA proteins and fibronectin in the activation of synovial cells from rheumatoid arthritis.In this study, our aim was to clarify whether the interaction of the very late antigen (VLA) on synovial cells from rheumatoid arthritis patients and that ligand, fibronectin is involvd in the pathogenesis of rheumatoid arthritis synovitis. First, we examined the expression of VLA proteins (VLA2, 3, 4, 5) on synovial tissues. VLA3, 4 and 5 proteins were expressed on the synovial lining and sublining cells. Lymphocytes mainly expressed VLA-4. Endothelial cells expressed VLA2, 3 and 5 proteins.When we compared the expression of VLA-4 protein among peripheral blood T cells, synovial T cells and synovial fluid T cells, we found the increased expression of VLA-4 on synovial fluid T cells, suggesting the existence of VLA-4 inducing substance in synovial fluid. Next, we examined whether fibronectin and that fragments affect the proliferation of synovial cells. Although they did not so, they induced the shape change of synovial A cells. When we detected the phosphorylated proteins in synovial cells after the stimulation of fibronectin, we did not get the constant pattern. Recently it was reported that the vascular cell adhesion molecule-1 (VCAM-1) was the other ligand of VLA-4 protein. Thereby, we examined the expression of VCAM-1 in the synovial tissues from rheumatoid arthritis patients. That expression was shown on the synovial lining and sublining cells. Since most of these cells express the VLA-4 protein, the interaction of these cells might be attributed to the binding of VLA-4 and VCAM-1 molecules.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
松山隆美: "VLA" 臨床検査. 37. 308-309 (1993)
Takami Matsuyama:“VLA”临床检查。37. 308-309 (1993)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
松山隆美: "RAにおけるT細胞とシグナル伝達異常" 医学のあゆみ. 161. 562-566 (1992)
Takami Matsuyama:“RA 中的 T 细胞和信号转导异常”《医学史》161. 562-566 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
松山 隆美: "RAにおけるT細胞とシグナル伝達異常" 医学のあゆみ. 161. 562-566 (1992)
Takami Matsuyama:“RA 中的 T 细胞和信号转导异常”《医学史》161. 562-566 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
松山隆美: "beta細胞の胚中心への接着にはVLA-4とINCAM-110が関与している" 臨床免疫. 24. 133-136 (1992)
Takami Matsuyama:“VLA-4 和 INCAM-110 参与 β 细胞与生发中心的粘附。” 临床免疫学 24. 133-136 (1992)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
22
    Therapy targeting folate receptor beta expressing macrophages in chronic inflammation
    • 批准号:
      23591441
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.49万
    • 财政年份:
      2011
    • 负责人:
      MATSUYAMA Takami
    • 依托单位:
    A preclinical study using recombinant anti-folate receptor-beta immunotoxin for the treatment of rheumatoid arthritis
    • 批准号:
      17591051
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2005
    • 负责人:
      MATSUYAMA Takami
    • 依托单位:
    The diagnostic and pathological significance of soluble CD163 in rheumatoid arthritis
    • 批准号:
      13670464
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      MATSUYAMA Takami
    • 依托单位:
    Inhibitory effects of membraneous beparin binding EGF like Factor on the apoptosis.
    • 批准号:
      11670453
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.54万
    • 财政年份:
      1999
    • 负责人:
      MATSUYAMA Takami
    • 依托单位:
    国内基金
    海外基金
    阻断LFA-1/VLA-4通路抑制CAR-T细胞中靶脱瘤毒性并增强T细胞记忆功能的机制研究
    • 批准号:
      82373249
    • 项目类别:
      面上项目
    • 资助金额:
      48万元
    • 批准年份:
      2023
    • 负责人:
      翟博
    • 依托单位:
    从DLI探索靶向干预VLA-4促进Allo-HSCT后HSC植入的作用及机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      宋献民
    • 依托单位:
    HIF-1α-SDF-1/CXCR4-VLA4在DS/CU靶向杀伤AML干细胞的作用及机制研究
    • 批准号:
      81400104
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2014
    • 负责人:
      郭绪涛
    • 依托单位:
    VLA-4 基因表达的调控及其在骨髓瘤抗药性中的作用
    • 批准号:
      81071743
    • 项目类别:
      面上项目
    • 资助金额:
      31.0万元
    • 批准年份:
      2010
    • 负责人:
      李志伟
    • 依托单位: